2018 American Transplant Congress
Obese Patients Show Resistance to Narcotics Reduction after TPIAT for Chronic Pancreatitis
Total pancreatectomy with islet autotransplantation (TPIAT) is an effective treatment option for chronic pancreatitis patients with refractory pain. Patients with high BMI (>30) are known…2018 American Transplant Congress
The Anterior Rectus Sheath Approach Resulted in No Difference in Wound Complication Rates in Obese versus Non-Obese Renal Transplant Recipients
The anterior rectus sheath (ARS) approach is a modification of the conventional Kuss procedure for kidney transplant (KT). We have previously described the ARS approach…2018 American Transplant Congress
Comparison of BMI, Waist Circumference and Waist-to-Height Ratio for Identification of Cardiovascular Risk in Pediatric Kidney Transplant Recipients
Children's National, Washington DC.
Background: Children with kidney disease have altered body composition and short stature that may not be accurately assessed by standard methods. The measure of obesity…2018 American Transplant Congress
Metabolic Regulation of Neuropeptides Induces Weight Loss and is Linked to Prolongation of Allograft Survival
Obesity has become a common comorbidity among transplant recipients that is linked to inferior transplant outcome through far-reaching effects on metabolism, inflammation and immunity. Increasingly,…2018 American Transplant Congress
Laparoscopic Donor Nephrectomy – The BMI Effect
Aims: To evaluate the outcomes of Laparoscopic Donor Nephrectomy (LDN) across 4 BMI groups.Methods : Using the SRTR database, all LDNs performed between 2006-2015 were…2018 American Transplant Congress
Robotic Pancreas Transplantation in Obese Recipients: Preliminary Results
1Surgery, University of Illinois, Chicago, IL; 2Surgery, University of Virginia, Virginia, VA.
IntroductionObesity is considered a relative contraindication to pancreas transplantation due to increased risks of wound and surgical related complications. Robotic surgery has never been applied…2018 American Transplant Congress
Differences in Rejection and Clinical Outcomes in Obese versus Non-Obese Renal Transplant Recipients Receiving Basiliximab Induction Immunosuppression
Introduction: Basilixiab is a fixed-dose IL-2 receptor antagonist that is used for non-lymphodepleting induction therapy. The impact of obesity on basiliximab pharmacokinetics and pharmacodynamics is…2018 American Transplant Congress
Weight Changes before and after Kidney Donation
IntroductionLiving kidney donors remain at low risk of end stage kidney disease but obese and overweight donors' risk is increased. We aimed to describe the…2018 American Transplant Congress
Pre-Donation Body Mass Index Associations with Outcomes in Living Kidney Donors: A Single Centre Experience
West London Renal and Transplant Centre, Imperial College NHS Trust, London, United Kingdom.
Background. Living kidney donor (LD) eligibility criteria have expanded as a result of excellent donor outcomes and increasing organ demand. However, considerable variability exists between…2018 American Transplant Congress
Adjusted Body Weight Dosing of Rabbit Antithymocyte Globulin in Obese Renal Transplant Recipients Preserves Excellent Clinical Outcomes at 3 Years and Improves the Value of Care
University of Virginia Health System, Charlottesville, VA.
There is significant variability in antithymocyte globulin (ATG) dosing practices among centers. In the obese population, use of total body weight (TBW) vs. adjusted body…
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 24
- Next Page »